Document Detail

Overexpression of vasopressin (V3) and corticotrophin-releasing hormone receptor genes in corticotroph tumours.
MedLine Citation:
PMID:  9876345     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: The molecular mechanisms underlying ACTH-secreting tumour formation remain unknown. Transmembrane signalling pathways play an important role in several endocrine disorders including pituitary tumours. To investigate the role of the pituitary vasopressin (V3) receptor (R) in ACTH-secreting tumours we have qualitatively and quantitatively analysed its mRNA. DESIGN: RT-PCR, denaturing gradient gel electrophoresis and S1 nuclease protection experiments were used to analyse V3 mRNA structure in ACTH-secreting tumours. We also developed a competitive RT-PCR system to compare the levels of expression of POMC, V3 and CRH-R genes. This system used as competitor a single mutant template (termed multi-mutant) containing primers for the three genes flanking an unrelated core sequence allowing multiple quantifications from the same cDNA preparations. We analysed 12 normal pituitaries, 15 corticotroph pituitary adenomas and 6 ACTH-secreting bronchial carcinoids. RESULTS: The V3 mRNA structure and sequence were found to be identical in normal and tumoural pituitary indicating that the tumoural Vs mRNA codes for a normal receptor. POMC RT-PCR signals in the pituitary tumour group were approximately 7-fold higher than in the normal pituitary group. Similarly, V3 and CRH-R signal were increased in pituitary tumors (mean +/- SEM: 5.87 x 10(-6) +/- 1.73 x 10(-6), and 2.33 x 10(-4) +/- 1.4 x 10(-4), respectively), when compared to normal pituitaries (1.19 x 10(-7) +/- 2.39 x 10(-8), and 1.7 x 10(-6) +/- 4.65 x 10(-7), respectively) suggesting that these two genes are expressed at very high levels in corticotroph tumours. When expressed relative to the corresponding POMC signals, increases in V3 and CRH-R signals reached 49-fold and 137-fold, respectively, in pituitary tumours. In ACTH-secreting bronchial carcinoids V3 gene expression level was also higher than in normal pituitary, whereas CRH-R signals were detected in only 4 of the 6 tumours with wide variations. CONCLUSION: Our results show that both vasopressin and CRH receptor genes are overexpressed in ACTH-secreting pituitary tumours. They suggest that overexpression of G protein-coupled receptors may be an additional mechanism through which membrane receptors may play a role in human tumours.
Y de Keyzer; P René; C Beldjord; F Lenne; X Bertagna
Related Documents :
22800825 - Effects of sirna specific to the protein kinase ck2α on apoptosis of laryngeal carcinom...
10790885 - Novel expression of hypothalamic neuropeptide y during postnatal development in the rat.
17636405 - Changes of glucocorticoid receptor and levels of crf mrna, pomc mrna in brain of chroni...
8898725 - C-fos mrna pattern and corticotropin-releasing factor neuronal activity throughout the ...
20564225 - Novel regulation of 25-hydroxyvitamin d3 24-hydroxylase (24(oh)ase) transcription by gl...
24107265 - The soluble decoy receptor 3 is regulated by a pi3k-dependent mechanism and promotes mi...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Clinical endocrinology     Volume:  49     ISSN:  0300-0664     ISO Abbreviation:  Clin. Endocrinol. (Oxf)     Publication Date:  1998 Oct 
Date Detail:
Created Date:  1999-01-11     Completed Date:  1999-01-11     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0346653     Medline TA:  Clin Endocrinol (Oxf)     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  475-82     Citation Subset:  IM    
Groupe d'Etudes en Physiopathologie Endocrinienne, Université René Descartes, Paris, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Adenoma / metabolism,  secretion*
Adrenocorticotropic Hormone / secretion*
Bronchial Neoplasms / metabolism
Carcinoid Tumor / metabolism
Gene Expression
Pituitary Gland / metabolism
Pituitary Neoplasms / metabolism,  secretion*
Pro-Opiomelanocortin / genetics
RNA, Messenger / analysis,  metabolism
Receptors, Corticotropin-Releasing Hormone / genetics*
Receptors, Vasopressin / genetics*
Reverse Transcriptase Polymerase Chain Reaction
Reg. No./Substance:
0/RNA, Messenger; 0/Receptors, Corticotropin-Releasing Hormone; 0/Receptors, Vasopressin; 66796-54-1/Pro-Opiomelanocortin; 9002-60-2/Adrenocorticotropic Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The IGF-I/IGFBP system in congenital partial lipodystrophy.
Next Document:  Responsiveness of IGF-I and IGFBP-3 to therapeutic intervention in children and adolescents with Cro...